These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 9680143)
41. A Broadly Reactive Human Anti-hemagglutinin Stem Monoclonal Antibody That Inhibits Influenza A Virus Particle Release. Yamayoshi S; Uraki R; Ito M; Kiso M; Nakatsu S; Yasuhara A; Oishi K; Sasaki T; Ikuta K; Kawaoka Y EBioMedicine; 2017 Mar; 17():182-191. PubMed ID: 28286060 [TBL] [Abstract][Full Text] [Related]
42. Electron microscopy of antibody complexes of influenza virus haemagglutinin in the fusion pH conformation. Wharton SA; Calder LJ; Ruigrok RW; Skehel JJ; Steinhauer DA; Wiley DC EMBO J; 1995 Jan; 14(2):240-6. PubMed ID: 7835335 [TBL] [Abstract][Full Text] [Related]
43. Comparative analysis of antibody induction and protection against influenza virus infection by DNA immunization with HA, HAe, and HA1 in mice. Chen J; Liu Q; Chen Q; Xiong C; Yao Y; Wang H; Wang H; Chen Z Arch Virol; 2014 Apr; 159(4):689-700. PubMed ID: 24132721 [TBL] [Abstract][Full Text] [Related]
44. An antibody that prevents the hemagglutinin low pH fusogenic transition. Barbey-Martin C; Gigant B; Bizebard T; Calder LJ; Wharton SA; Skehel JJ; Knossow M Virology; 2002 Mar; 294(1):70-4. PubMed ID: 11886266 [TBL] [Abstract][Full Text] [Related]
45. Inhibition of influenza virus hemagglutinin-mediated membrane fusion by a compound related to podocarpic acid. Staschke KA; Hatch SD; Tang JC; Hornback WJ; Munroe JE; Colacino JM; Muesing MA Virology; 1998 Sep; 248(2):264-74. PubMed ID: 9721235 [TBL] [Abstract][Full Text] [Related]
46. Natural influenza A virus infection of mice elicits strong antibody response to HA2 glycopolypeptide. Kostolanský F; Mucha V; Slováková R; Varecková E Acta Virol; 2002; 46(4):229-36. PubMed ID: 12693859 [TBL] [Abstract][Full Text] [Related]
47. Exploring the early stages of the pH-induced conformational change of influenza hemagglutinin. Zhou Y; Wu C; Zhao L; Huang N Proteins; 2014 Oct; 82(10):2412-28. PubMed ID: 24854389 [TBL] [Abstract][Full Text] [Related]
48. An epitope shared by the hemagglutinins of H1, H2, H5, and H6 subtypes of influenza A virus. Smirnov YA; Lipatov AS; Gitelman AK; Okuno Y; Van Beek R; Osterhaus AD; Claas EC Acta Virol; 1999 Aug; 43(4):237-44. PubMed ID: 10749369 [TBL] [Abstract][Full Text] [Related]
49. Changes in the influenza virus haemagglutinin at acid pH detected by monoclonal antibodies to glycopolypeptides HA1 and HA2. Kostolansky F; Russ G; Mucha V; Styk B Arch Virol; 1988; 101(1-2):13-24. PubMed ID: 2458086 [TBL] [Abstract][Full Text] [Related]
50. Isolation and immunogenic properties of a monomeric form of the HA1 subunit of the influenza virus haemagglutinin from infected cells. Weber C; Scheepers K; Linder D; Becht H J Gen Virol; 1993 Dec; 74 ( Pt 12)():2793-7. PubMed ID: 8277289 [TBL] [Abstract][Full Text] [Related]
52. Monoclonal antibodies demonstrate accessible HA2 epitopes in minor subpopulation of native influenza virus haemagglutinin molecules. Varecková E; Mucha V; Ciampor F; Betáková T; Russ G Arch Virol; 1993; 130(1-2):45-56. PubMed ID: 7684894 [TBL] [Abstract][Full Text] [Related]
53. Spin-labeling of influenza virus hemagglutinin permits analysis of the conformational change at low pH and its inhibition by antibody. Yoden S; Kida H; Kuwabara M; Yanagawa R; Webster RG Virus Res; 1986 May; 4(3):251-61. PubMed ID: 3017016 [TBL] [Abstract][Full Text] [Related]
54. Delay of influenza hemagglutinin refolding into a fusion-competent conformation by receptor binding: a hypothesis. Leikina E; Markovic I; Chernomordik LV; Kozlov MM Biophys J; 2000 Sep; 79(3):1415-27. PubMed ID: 10969003 [TBL] [Abstract][Full Text] [Related]
55. Identification of a novel HA conformational change inhibitor of human influenza virus. Yoshimoto J; Kakui M; Iwasaki H; Fujiwara T; Sugimoto H; Hattori N Arch Virol; 1999; 144(5):865-78. PubMed ID: 10416371 [TBL] [Abstract][Full Text] [Related]
56. Generation of monoclonal pan-hemagglutinin antibodies for the quantification of multiple strains of influenza. Manceur AP; Zou W; Marcil A; Paquet E; Gadoury C; Jaentschke B; Li X; Petiot E; Durocher Y; Baardsnes J; Rosa-Calatrava M; Ansorge S; Kamen AA PLoS One; 2017; 12(6):e0180314. PubMed ID: 28662134 [TBL] [Abstract][Full Text] [Related]
57. Changes in the antigenicity of the hemagglutinin molecule of H3 influenza virus at acidic pH. Webster RG; Brown LE; Jackson DC Virology; 1983 Apr; 126(2):587-99. PubMed ID: 6190310 [TBL] [Abstract][Full Text] [Related]
58. Conformational changes and fusion activity of influenza virus hemagglutinin of the H2 and H3 subtypes: effects of acid pretreatment. Puri A; Booy FP; Doms RW; White JM; Blumenthal R J Virol; 1990 Aug; 64(8):3824-32. PubMed ID: 2196382 [TBL] [Abstract][Full Text] [Related]
59. Antigenic structure of the haemagglutinin of human influenza A/H2N2 virus. Tsuchiya E; Sugawara K; Hongo S; Matsuzaki Y; Muraki Y; Li ZN; Nakamura K J Gen Virol; 2001 Oct; 82(Pt 10):2475-2484. PubMed ID: 11562540 [TBL] [Abstract][Full Text] [Related]
60. Development of a high-throughput assay to detect antibody inhibition of low pH induced conformational changes of influenza virus hemagglutinin. Trost JF; LeMasters EH; Liu F; Carney P; Lu X; Sugawara K; Hongo S; Stevens J; Steinhauer DA; Tumpey T; Katz JM; Levine MZ; Li ZN PLoS One; 2018; 13(6):e0199683. PubMed ID: 29949635 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]